Risk of post-procedural thromboembolic events with warfarin versus new oral anticoagulants in atrial fibrillation patients undergoing catheter ablation
机构:[1]Texas Cardiac Arrhythmia Inst, St Davids Med Ctr, Austin, TX USA;[2]Beijing Anzhen Hosp, Beijing, Peoples R China;首都医科大学附属安贞医院[3]Calif Pacific Med Ctr, San Francisco, CA USA
第一作者机构:[1]Texas Cardiac Arrhythmia Inst, St Davids Med Ctr, Austin, TX USA;
推荐引用方式(GB/T 7714):
Mohanty S.,Trivedi C.,Gianni C.,et al.Risk of post-procedural thromboembolic events with warfarin versus new oral anticoagulants in atrial fibrillation patients undergoing catheter ablation[J].EUROPEAN HEART JOURNAL.2016,37:1082-1082.
APA:
Mohanty, S.,Trivedi, C.,Gianni, C.,Gokoglan, Y.,Bai, R....&Natale, A..(2016).Risk of post-procedural thromboembolic events with warfarin versus new oral anticoagulants in atrial fibrillation patients undergoing catheter ablation.EUROPEAN HEART JOURNAL,37,
MLA:
Mohanty, S.,et al."Risk of post-procedural thromboembolic events with warfarin versus new oral anticoagulants in atrial fibrillation patients undergoing catheter ablation".EUROPEAN HEART JOURNAL 37.(2016):1082-1082